Publikationen, an denen er mitarbeitet Koldo García Etxebarria (24)

2024

  1. A Novel, Noninvasive Method to Diagnose Active Eosinophilic Esophagitis, Combining Clinical Data and Oral Cavity RNA Levels

    Clinical Gastroenterology and Hepatology

  2. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

    Therapeutic Advances in Gastroenterology, Vol. 17

  3. Stratified analyses refine association between TLR7 rare variants and severe COVID-19

    Human Genetics and Genomics Advances, Vol. 5, Núm. 4

2023

  1. A 1 year course of starch- and sucrose-reduced diet used by irritable bowel syndrome patients with diarrhoea and the effect of genetic variants

    Frontiers in Nutrition, Vol. 10

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  4. Genetic Variants as Predictors of the Success of Colorectal Cancer Treatments

    Cancers, Vol. 15, Núm. 19

  5. Identification of taxonomic changes in the fecal bacteriome associated with colorectal polyps and cancer: potential biomarkers for early diagnosis

    Frontiers in Microbiology, Vol. 14

  6. Sucrase-isomaltase genotype and response to a starch-reduced and sucrose-reduced diet in IBS-D patients

    Gut

  7. The effect of starch- and sucrose-reduced diet accompanied by nutritional and culinary recommendations on the symptoms of irritable bowel syndrome patients with diarrhoea

    Therapeutic Advances in Gastroenterology, Vol. 16

2022

  1. A survey of functional dyspepsia in 361,360 individuals: Phenotypic and genetic cross-disease analyses

    Neurogastroenterology and Motility, Vol. 34, Núm. 6

  2. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  3. Local genetic variation of inflammatory bowel disease in Basque population and its effect in risk prediction

    Scientific Reports, Vol. 12, Núm. 1

  4. Performance of the Use of Genetic Information to Assess the Risk of Colorectal Cancer in the Basque Population

    Cancers, Vol. 14, Núm. 17

2021

  1. GWAS of stool frequency provides insights into gastrointestinal motility and irritable bowel syndrome

    Cell Genomics, Vol. 1, Núm. 3

  2. Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders

    Nature Genetics, Vol. 53, Núm. 11, pp. 1543-1552

  3. Interplay between genome, metabolome and microbiome in colorectal cancer

    Cancers, Vol. 13, Núm. 24

  4. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2020

  1. Food groups, diet quality and colorectal cancer risk in the Basque Country

    World journal of gastroenterology, Vol. 26, Núm. 28, pp. 4108-4125

  2. Gene-Diet Interactions in Colorectal Cancer: Survey Design, Instruments, Participants and Descriptive Data of a Case-Control Study in the Basque Country

    Nutrients, Vol. 12, Núm. 8